Predicted Trait | |
Reported Trait | Type 1 diabetes (T1D) |
Mapped Trait(s) | type 1 diabetes mellitus (MONDO_0005147) |
Score Construction | |
PGS Name | T1D_GRS |
Development Method | |
Name | Genome-wide significant variants |
Parameters | Literature curated SNPs and HLA haplotypes. Based off of Oram et al. (2016; PMID:26577414) & Patel et al. (2016; PMID:27207547) |
Variants | |
Original Genome Build | NR |
Number of Variants | 37 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000012 |
Citation (link to publication) | Perry DJ et al. Sci Rep (2018) |
Ancestry Distribution | |
PGS Evaluation | African: 33.3% Hispanic or Latin American: 33.3% European: 33.3% 3 Sample Sets |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM000042 | PSS000029| European Ancestry| 1,447 individuals |
PGP000012 | Perry DJ et al. Sci Rep (2018) |
Reported Trait: Type 1 diabetes | — | AUROC: 0.8508 | — | — | AUROCs are reported with respect to unrelated-control samples |
PPM000043 | PSS000028| Hispanic or Latin American Ancestry| 252 individuals |
PGP000012 | Perry DJ et al. Sci Rep (2018) |
Reported Trait: Type 1 diabetes | — | AUROC: 0.9003 | — | — | AUROCs are reported with respect to unrelated-control samples |
PPM000044 | PSS000027| African Ancestry| 299 individuals |
PGP000012 | Perry DJ et al. Sci Rep (2018) |
Reported Trait: Type 1 diabetes | — | AUROC: 0.7522 | — | — | AUROCs are reported with respect to unrelated-control samples |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS000027 | Type 1 diabetes status was assigned according to clinician diagnosis. | — | [ ,
33.78 % Male samples |
— | African American or Afro-Caribbean | — | UFDI | Total sample number contains the number of controls, cases, and includes the number of first/second-degree relatives and samples identified as "at risk" (autoantibody positive) used in other analyses. |
PSS000028 | Type 1 diabetes status was assigned according to clinician diagnosis. | — | [ ,
44.84 % Male samples |
— | Hispanic or Latin American | Samples labeled Caucasian (Hispanic ethnicity) in the original publication. | UFDI | Total sample number contains the number of controls, cases, and includes the number of first/second-degree relatives and samples identified as "at risk" (autoantibody positive) used in other analyses. |
PSS000029 | Type 1 diabetes status was assigned according to clinician diagnosis. | — | [ ,
47.34 % Male samples |
— | European | Samples labeled Caucasian (non-Hispanic) in the original publication. | UFDI | Total sample number contains the number of controls, cases, and includes the number of first/second-degree relatives and samples identified as "at risk" (autoantibody positive) used in other analyses. |